Log in to search using one of your social media accounts:

 

Theranostics: Paintball targeting of cancer cells combined with precision therapy
(Society of Nuclear Medicine) The Journal of Nuclear Medicine's September supplement shines a spotlight on theranostics and its increasingly important role in delivering precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands (which lock onto the specific cancer cell receptor/biomarker), with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed -- minimizing side effects and improving quality of life for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 13, 2017 Category: Cancer & Oncology Source Type: news

Double targeting ligands to identify and treat prostate cancer
(Society of Nuclear Medicine) Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. The study is presented in the featured basic article of the September issue of the Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 7, 2017 Category: Cancer & Oncology Source Type: news

New technique gives a clearer image of immunotherapy results in advanced brain cancer
FINDINGSResearchers led by Robert Prins, a member of the UCLA Jonsson Comprehensive Cancer Center, have developed a new approach for brain imaging that can better distinguish immune responses from tumor growth in both preclinical studies and in people with glioblastoma.BACKGROUNDDespite clinical advances in immunotherapy for cancer, non-invasive monitoring of tumor growth (especially in people with brain tumors) has been a significant problem. When clinicians use traditional medical imaging processes, the inflammation that sometimes results from immunotherapies can resemble neurological decline and tumor growth.METHODPrins...
Source: UCLA Newsroom: Health Sciences - September 5, 2017 Category: Universities & Medical Training Source Type: news

FDG-PET/CT predicts melanoma patients' response to immune checkpoint inhibitor therapy
(Society of Nuclear Medicine) Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined PET/CT scanning early in treatment of advanced melanoma could identify whether the therapy will benefit a particular patient. As the therapy has potentially serious side-effects, early determination of ineffectiveness could avert unnecessary risk exposure and provide the option of a different treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 5, 2017 Category: Cancer & Oncology Source Type: news

SNMMI 2017-2019 Wagner-Torizuka Fellowship recipients announced
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce the recipients of the 2017-2019 SNMMI Wagner-Torizuka Fellowship. This two-year fellowship, founded in 2008 by the late Henry N. Wagner, Jr., MD, and the late Kanji Torizuka, MD, PhD, is designed to provide extensive training and experience in the fields of nuclear medicine and molecular imaging for Japanese physicians in the early stages of their careers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news

First human application of novel PET tracer for prostate cancer
(Society of Nuclear Medicine) In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 7, 2017 Category: Cancer & Oncology Source Type: news

SNMMI posts use criteria for hepatobiliary scintigraphy
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published...Read more on AuntMinnie.comRelated Reading: SNMMI Image of the Year awarded to German researchers SNMMI taps new slate of officers for 2017-2018 SNMMI partners with NDSC on appropriate use criteria SNMMI offers appropriate use criteria for 2 cancers SNMMI gets nod from CMS for appropriate use criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 4, 2017 Category: Radiology Source Type: news

SNMMI publishes appropriate use criteria for hepatobiliary scintigraphy in abdominal pain
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for hepatobiliary scintigraphy in abdominal pain. This is the third in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for Advanced Diagnostic Imaging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2017 Category: International Medicine & Public Health Source Type: news

SNMMI honors outstanding contributors at 2017 annual meeting
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2017 Category: International Medicine & Public Health Source Type: news

New imaging tracer allows early assessment of abdominal aortic aneurysm risk
(Society of Nuclear Medicine) Yale University researchers have developed a way in which medical imaging with SPECT/CT could potentially be used to assess a patient's rupture risk for abdominal aortic aneurysm. Delaying surgical treatment can be life-threatening, and this new type of imaging could allow physicians to diagnose disease and better plan its management. The study is presented in the featured article of the August issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2017 Category: International Medicine & Public Health Source Type: news

Europe Backs Nuclear Medicine for Cancer That Killed Steve Jobs Europe Backs Nuclear Medicine for Cancer That Killed Steve Jobs
A nuclear medicine targeting gastroenteropancreatic neuroendocrine tumours (NETs) won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 24, 2017 Category: Radiology Tags: Radiology News Source Type: news

Europe backs nuclear medicine for cancer that killed Steve Jobs
LONDON (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications. (Source: Reuters: Health)
Source: Reuters: Health - July 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

SNMMI technologist section announces 2017 award winners
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging's Technologist Section (SNMMI-TS) -- an international scientific and medical organization --r ecognized contributions to and work in the field of nuclear medicine and molecular imaging during the SNMMI 2017 Annual Meeting in Denver, Colorado, held June 10-14. Several awards ceremonies were held to recognize the valuable role that SNMMI-TS members play in advancing the discipline of nuclear medicine technology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 20, 2017 Category: Cancer & Oncology Source Type: news

Phase II Ssudy: Radiotherapy dose increase to hypoxic NSCLC lesions
(Society of Nuclear Medicine) Fluorine-18-fluoromisonidazole (FMISO) is a PET radiotracer that is widely used to diagnose hypoxia (insufficient oxygen supply to tissue), and non-small cell lung cancer (NSCLC) patients with FMISO uptake are known to face a poor prognosis. A multicenter French Phase II study featured in the July issue of The Journal of Nuclear Medicine investigated whether a selective radiotherapy dose increase to tumor areas with significant FMISO uptake in NSCLC patients could improve outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2017 Category: Cancer & Oncology Source Type: news

Phase II Study: Radiotherapy dose increase to hypoxic NSCLC lesions
(Society of Nuclear Medicine) Fluorine-18-fluoromisonidazole (FMISO) is a PET radiotracer that is widely used to diagnose hypoxia (insufficient oxygen supply to tissue), and non-small cell lung cancer (NSCLC) patients with FMISO uptake are known to face a poor prognosis. A multicenter French Phase II study featured in the July issue of The Journal of Nuclear Medicine investigated whether a selective radiotherapy dose increase to tumor areas with significant FMISO uptake in NSCLC patients could improve outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2017 Category: Cancer & Oncology Source Type: news

Novel PET tracer detects small blood clots
(Society of Nuclear Medicine) Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine's July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 labeled ligand is a promising approach for diagnostic imaging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2017 Category: International Medicine & Public Health Source Type: news

The Journal of Nuclear Medicine impact factor increases
(Society of Nuclear Medicine) The Journal of Nuclear Medicine (JNM) -- the flagship publication of the Society of Nuclear Medicine and Molecular Imaging -- is again ranked among the top medical imaging journals worldwide, according to the 2016 Journal Citation Reports © published by Thomson Reuters. JNM's impact factor went up from 5.849 to 6.646. Among nuclear medicine journals, JNM has the highest number of citations and citable articles, the highest average five-year impact factor, and the highest influence score. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2017 Category: International Medicine & Public Health Source Type: news

SNMMI: Education eases patients' nuclear medicine fears
DENVER - By providing basic educational materials on nuclear medicine and the...Read more on AuntMinnie.comRelated Reading: JNM article questions radiation dangers for kids Education enlightens patients to radiologist's role Are radiation dose guidelines scaring patients? Most hospitals follow pediatric nuclear medicine dose guidelines Does low-level radiation really cause cancer? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 15, 2017 Category: Radiology Source Type: news

SNMMI Image of the Year awarded to German researchers
DENVER - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) on Wednesday...Read more on AuntMinnie.comRelated Reading: Novel PET combination awarded SNMMI Image of the Year SNMMI: PET prostate image lands Image of the Year honors SNMMI: Alzheimer's PET tracer wins Image of the Year award Radium-223 dichloride is focus of SNMMI Image of the Year SNM Image of the Year goes to Bi-123 DOTATOC radiotracer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2017 Category: Radiology Source Type: news

SNMMI Image of the Year: PET and optical imaging for prostate cancer diagnosis and therapy
(Society of Nuclear Medicine) The winning image, presented by German researchers at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), clearly demonstrates how combining the advantages of 68Ga-PSMA PET and intraoperative gamma and fluorescence imaging results in better tumor identification before and during surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2017 Category: Cancer & Oncology Source Type: news

Dual-agent PET/MR with time of flight detects more cancer
(Society of Nuclear Medicine) Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) followed by quantitative scanning significantly improves image quality and detection of bone metastases at a lower dose, according to research presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2017 Category: Cancer & Oncology Source Type: news

Prostate PET/CT targets more cancer and improves patient care
(Society of Nuclear Medicine) A new study that includes data from four Australian medical centers shows that Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT detects prostate cancer not caught by more conventional imaging, thus affecting treatment plans. The research was presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2017 Category: Cancer & Oncology Source Type: news

Targeted radionuclide treatment for neuroendocrine tumours improves quality of life
A study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging reports that a novel peptide receptor radionuclide therapy significantly improves wellbeing for patients with malignant neuroendocrine tumours.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 13, 2017 Category: Endocrinology Source Type: news

Immuno-PET shows promise for detecting and treating pancreatic tumors
(Society of Nuclear Medicine) A first-in-human study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the feasibility and safety of the novel human monoclonal antibody HuMab-5B1 with highly specific targeting for the cancer antigen (CA) 19-9, which is expressed on pancreatic tumors and a variety of other malignancies, including small cell lung cancer and tumors of the gastrointestinal system. It holds the promise of better identifying tumors and directing treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 13, 2017 Category: Cancer & Oncology Source Type: news

Single dual time-point PET scan identifies dual Alzheimer's biomarkers
(Society of Nuclear Medicine) Identifying Alzheimer's disease before major symptoms arise is critical to preserving brain function and helping patients maintain quality of life. A new study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates that a single dual time-point PET scan could identify important biomarkers of the disease. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 13, 2017 Category: International Medicine & Public Health Source Type: news

Combining radionuclide therapy with a PARP inhibitor slows neuroendocrine tumor growth
(Society of Nuclear Medicine) Patients with neuroendocrine tumors (NETs) may experience fewer symptoms and survive longer by undergoing peptide-receptor radionuclide therapy (PRRT) combined with a drug that makes tumor cells more sensitive to radiation therapy, say researchers presenting at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2017 Category: International Medicine & Public Health Source Type: news

Personalized PRRT improves radiation delivery to neuroendocrine tumors
(Society of Nuclear Medicine) Neuroendocrine cancer is exceedingly difficult to manage and unlikely to be cured, but researchers intend to slow progression of these tumors and aid survival by personalizing patient dose of peptide-receptor radionuclide therapy (PRRT), according to research presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2017 Category: International Medicine & Public Health Source Type: news

At annual meeting, SNMMI recognizes new fellows for distinguished service
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognized seven new SNMMI Fellows during a Special Plenary Session at the society's 2017Annual Meeting, held June 10-14 in Denver, Colorado. The SNMMI Fellowship was established last year to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is one of the most prestigious formal recognitions available to long-time SNMMI members. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2017 Category: International Medicine & Public Health Source Type: news

Targeted radionuclide treatment for neuroendocrine tumors improves quality of life
(Society of Nuclear Medicine) Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life. A study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a novel peptide receptor radionuclide therapy (PRRT) is significantly improving patient wellbeing. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2017 Category: Cancer & Oncology Source Type: news

Martin G. Pomper, MD, PhD, receives SNMMI Paul C. Aebersold Award in nuclear medicine
(Society of Nuclear Medicine) Martin G. Pomper, MD, PhD, director of nuclear medicine and molecular imaging and professor in the Russell H. Morgan Department of Radiology and Radiological Science at The Johns Hopkins University School of Medicine in Baltimore, Maryland, has been named the 2017 recipient of the prestigious Paul C. Aebersold Award. Pomper was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its annual meeting, held June 10-14 in Denver, Colorado. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2017 Category: Cancer & Oncology Source Type: news

Targeted photodynamic therapy shown highly effective against prostate cancer
(Society of Nuclear Medicine) Researchers presenting a preclinical study at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrated the efficacy and optimal dose for targeted photodynamic therapy (tPDT) to treat prostate cancer before and during surgery. Prostate-specific membrane antigen (PSMA) was targeted with an anti-PSMA antibody radiolabeled with the tracer indium-111 (111In) and coupled with specialized photosensitizers that cause cell destruction upon exposure to near-infrared (NIR). The combined formula is 111In-DTPA-D2B-IRDye700DX. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2017 Category: Cancer & Oncology Source Type: news

ec2 to acquire software firm Numa
In a move that will unite developers of nuclear medicine software, ec2 Software...Read more on AuntMinnie.comRelated Reading: Numa debuts dose reporting software at RSNA 2016 BioDose and NMIS rebrand as ec2 Software Numa adopts virtual model for software Numa announces molecular agreement with Siemens Numa to debut workflow package at SNM show (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 9, 2017 Category: Radiology Source Type: news

JNM article questions radiation dangers for kids
A group of researchers are taking issue with the widely held theory that even...Read more on AuntMinnie.comRelated Reading: Are radiation dose guidelines scaring patients? Most hospitals follow pediatric nuclear medicine dose guidelines Article blasts LNT theory of radiation harm U.S. NRC starts review of LNT radiation theory Does low-level radiation really cause cancer? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 8, 2017 Category: Radiology Source Type: news

SNMMI partners with NDSC on appropriate use criteria
The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) Imaging Appropriate...Read more on AuntMinnie.comRelated Reading: SNMMI offers appropriate use criteria for 2 cancers SNMMI to Trump: Rescind travel ban SNMMI gets nod from CMS for appropriate use criteria SNMMI names top leaders for 2016-2017 SNMMI rejects plan to dissolve ABNM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 7, 2017 Category: Radiology Source Type: news

Diagnostic radiation exposure safe for children, experts state
(Society of Nuclear Medicine) In an article published in the June issue of The Journal of Nuclear Medicine, researchers assert that exposure to medical imaging radiation not only doesn't increase an adult person's risk of getting cancer, it doesn't increase a child's risk. They state that the long-held belief even low doses of radiation, such as those received in diagnostic imaging, increase cancer risk is based on an inaccurate, 70-year-old hypothesis and leads to unnecessary fear and misdiagnoses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2017 Category: International Medicine & Public Health Source Type: news

PET/MR shows arterial CO2 as potent vasodilator for cardiac stress testing
(Society of Nuclear Medicine) Using PET/MR imaging, a new international study featured in the June issue of The Journal of Nuclear Medicine demonstrates that increases in partial pressure of arterial carbon dioxide (PaCO2) can safely and efficiently widen blood vessels of the heart during stress tests to help determine heart function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 5, 2017 Category: International Medicine & Public Health Source Type: news

Combined optical and molecular imaging could guide breast-conserving surgery
(Society of Nuclear Medicine) Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries. Now, in a first-in-human study, British researchers have provided a possible solution using Cerenkov luminescence imaging (CLI), which combines optical and molecular imaging. The study is covered in the featured article of The Journal of Nuclear Medicine's June 2017 issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2017 Category: Cancer & Oncology Source Type: news

UC Davis signs licensing agreement for breast CT
University of California, Davis (UC Davis) has signed a licensing agreement...Read more on AuntMinnie.comRelated Reading: Samsung NeuroLogica wins CT installation at UC Davis Chinese nuclear medicine firm comes to U.S. Zecotek sells PET crystals to UC Davis UC Davis gets $15.5M grant for total-body PET scanner UC Davis group wins CT lung nodule surveillance grant (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 25, 2017 Category: Radiology Source Type: news

Mark Wallenmeyer Named NWACC Dean of Health Professions
BENTONVILLE – Mark Wallenmeyer has been named the new dean of the Health Professions Division at Northwest Arkansas Community College. Wallenmeyer, who currently serves as the program director of the Nuclear Medicine Advanced Associate and Nuclear Medicine Imaging Sciences Program at the University of Arkansas for Medical Sciences, will join the college on July 1. Wallenmeyer received his bachelor’s degree in biology from Southwest Baptist University and then earned a certificate of Nuclear Medicine from Baylor before completing his MBA in health care administration from the University of Phoenix. He joine...
Source: Arkansas Business - Health Care - May 23, 2017 Category: American Health Source Type: news

The SNMMI Annual Meeting: Reaching new heights in the mile-high city
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging's 2017 Annual Meeting will be held in Denver, Colorado, June 10-14. It will bring together more than 5,000 physicians, technologists, scientists and exhibitors from around the globe to share and learn about cutting-edge research, advance their knowledge through continuing education sessions, and network. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2017 Category: International Medicine & Public Health Source Type: news

SPECT/CT combined with fluorescence imaging detects micrometastases
(Society of Nuclear Medicine) Researchers in The Netherlands have demonstrated that combining SPECT/CT and fluorescence imaging could help surgeons differentiate tumor tissue from normal tissue. The research is detailed in the featured basic science article of the May 2017 issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2017 Category: Cancer & Oncology Source Type: news

PET/CT helps assess pediatric brain tumor therapy
In a new study published in the May issue of the Journal of Nuclear Medicine,...Read more on AuntMinnie.comRelated Reading: SNMMI: FDOPA-PET/MRI monitors pediatric brain tumors SNMMI: PET, MRI may predict pediatric brain tumor outcomes SNMMI: FET-PET aids pediatric brain cancer patients SNM: PET/MRI helps tumor staging for pediatric patients Proton therapy offers hope to pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2017 Category: Radiology Source Type: news

SNMMI publishes criteria for V/Q studies of PE
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published...Read more on AuntMinnie.comRelated Reading: SNMMI offers appropriate use criteria for 2 cancers SNMMI gets nod from CMS for appropriate use criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 2, 2017 Category: Radiology Source Type: news

PET/CT helps predict therapy effectiveness in pediatric brain tumors
(Society of Nuclear Medicine) In this first ever molecular drug-imaging study in children, researchers in The Netherlands used whole-body positron emission tomography/computed tomography (PET/CT) scans to determine whether bevacizumab (Avastin) treatment of diffuse intrinsic pontine glioma (DIPG) in children is likely to be effective. The study is featured in the May 2017 issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2017 Category: Global & Universal Source Type: news

SNMMI publishes appropriate use criteria for V/Q imaging in pulmonary embolism
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging has published appropriate use criteria for ventilation/perfusion (V/Q) imaging in pulmonary embolism. This is the second in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2017 Category: Global & Universal Source Type: news

How Good Are Ankle Rules for Determining If a Patient Needs An X-Ray?
This study supports that if the clinical examination indicates a low risk injury, then radiographs are not indicated. If the examination indicates a potential high risk injury, then the radiographs would be indicated because the clinical examination cannot discern well enough if a fracture is present or not. Use of the Low Risk Ankle Rule was evaluated in a Canadian study of 3-16 year old children. The study found a decrease in radiographs by 22% using the Low Risk Ankle Rules. Overall the sensitivity was 100% and the specificity was 53.1%. This study supports that if the examination indicates a low risk injury, then rad...
Source: PediatricEducation.org - May 1, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medical News Today: Barium swallow: What to expect and side effects
Barium is a white liquid used to coat the organs of the digestive system during an X-ray. Learn about the procedure in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 27, 2017 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

GE Healthcare, Lantheus ink PET imaging agent development deal
GE Healthcare (NYSE:GE) and Lantheus Holdings(NSDQ:LNTH) said today they inked a definitive license agreement to continue the Phase III development and commercialization of the investigational flurpiridaz F 18 imaging agent. The imaging agent is designed as a positron emission tomography myocardial perfusion imaging agent that the companies say may improve the diagnosis of coronary artery disease. The deal follows the inking of a term sheet announced in February, the companies said. “We are committed to strengthening and expanding our nuclear portfolio through this strategic partnership with Lantheus and potenti...
Source: Mass Device - April 25, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Imaging Research & Development GE Healthcare Lantheus Medical Imaging Source Type: news

PET radiotracer design for monitoring targeted immunotherapy
(Society of Nuclear Medicine) In an article published in the April issue of 'The Journal of Nuclear Medicine,' researchers at Stanford University in California provide a template for assessing new positron emission tomography (PET) radiotracers that can accurately identify molecules in cancer cells that prevent the immune system from attacking the cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 7, 2017 Category: Cancer & Oncology Source Type: news

SNMMI publishes appropriate use criteria for bone scintigraphy in prostate and breast cancer
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging has published appropriate use criteria (AUC) for bone scintigraphy (scans to identify bone metastases) in patients with prostate or breast cancer. This is the first in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2017 Category: Cancer & Oncology Source Type: news